Evidence map›Paper›PMID 38356912›Full record

ArticleFrontiers in psychiatry2024

Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia.

Giulia M Giordano, Pasquale Pezzella, Armida Mucci, Stephen F Austin, Andreas Erfurth, Birte Glenthøj, Alex Hofer, Jan Hubenak, Jan Libiger, Ingrid Melle and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Reading body and face language in male schizophrenia.Schizophrenia (Heidelberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. High-density EEG study in patients with schizophrenia treated with cariprazine.The international journal of neuropsychopharmacology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. The role of affective states in computational psychiatry.The international journal of neuropsychopharmacology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 6 countries.

Giulia M GiordanoDepartment of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
Pasquale PezzellaDepartment of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
Armida MucciDepartment of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
Stephen F AustinPsychiatric Research Unit, Region Zealand Psychiatry, Slagelse, Denmark.
Andreas Erfurth6th Psychiatric Department, Otto-Wagner-Spital, Vienna, Austria.
Birte GlenthøjCenter for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Glostrup, Denmark.
Alex HoferMedical University Innsbruck, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Division of Psychiatry I, Innsbruck, Austria.
Jan HubenakDepartment of Psychiatry, Charles University, Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czechia.
Jan LibigerDepartment of Psychiatry, Charles University, Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czechia.
Ingrid MelleNORMENT Centre, Institute of Clinical Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway.
Mette Ø NielsenCenter for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Glostrup, Denmark.
Janusz K RybakowskiDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Pawel WojciakDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Silvana Galderisi *Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
Gabriele Sachs *Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
University of Campania "Luigi Vanvitelli" · ITPoznan University of Medical Sciences · PLCharles University · CZGlostrup Hospital · DKInnsbruck Medical University · ATMedical University of Vienna · ATOtto Wagner Hospital · ATRegion Zealand · DKUniversity Hospital Hradec Králové · CZUniversity of Copenhagen · DKUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In this study we assessed the contribution of psychopathology, including the two domains of negative symptoms (motivational deficit and expressive deficit), processing speed as an index of neurocognition, and emotion recognition, as an index of social cognition, to poor functional outcomes in people with schizophrenia. Methods: The Positive and Negative Syndrome Scale was used to evaluate positive symptoms and disorganization and the Brief Negative Symptom Scale to assess negative symptoms. The Symbol Coding and the Trail Making Test A and B were used to rate processing speed and the Facial Emotion Identification Test to assess emotion recognition. Functional outcome was assessed with the Personal and Social Performance Scale (PSP). Regression analyses were performed to identify predictors of functional outcome. Mediation analyses was used to investigate whether social cognition and negative symptom domains fully or partially mediated the impact of processing speed on functional outcome. Results: One hundred and fifty subjects from 8 different European centers were recruited. Our data showed that the expressive deficit predicted global functioning and together with motivational deficit fully mediated the effects of neurocognition on it. Motivational deficit was a predictor of personal and social functioning and fully mediated neurocognitive impairment effects on the same outcome. Both motivational deficit and neurocognitive impairment predicted socially useful activities, and the emotion recognition domain of social cognition partially mediated the impact of neurocognitive deficits on this outcome. Conclusions: Our results indicate that pathways to functional outcomes are specific for different domains of real-life functioning and that negative symptoms and social cognition mediate the impact of neurocognitive deficits on different domains of functioning. Our results suggest that both negative symptoms and social cognition should be targeted by psychosocial interventions to enhance the functional impact of neurocognitive remediation.

Indexed as

emotion recognitionexpressive deficitmediation analysismotivational deficitnegative symptomsprocessing speedschizophrenia

Identifiers

PMID38356912
PMCPMC10864497
OpenAlexW4391397365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.